Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo
about
Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compoundEfficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infectionsEfficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of vaccinia virus (orthopoxvirus) infections in miceVaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infectionsSusceptibilities of zidovudine-resistant variants of human immunodeficiency virus type 1 to inhibition by acyclic nucleoside phosphonatesDifferential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurineEfficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in miceCharacterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.Inhibitory effect of 9-(2-phosphonylmethoxyethyl)adenine on visna virus infection in lambs: a model for in vivo testing of candidate anti-human immunodeficiency virus drugs.Acyclic nucleoside phosphonates: a key class of antiviral drugs.Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cellsIn search of a selective antiviral chemotherapy.Effects of phosphonylmethoxyalkyl derivatives studied with a murine model for abortion induced by equine herpesvirus 1.Orthopoxvirus targets for the development of antiviral therapies.Effect of oral treatment with hexadecyloxypropyl-[(S)-9-(3-hydroxy-2- phosphonylmethoxypropyl)adenine] [(S)-HPMPA] or octadecyloxyethyl-(S)-HPMPA on cowpox or vaccinia virus infections in miceActivities of certain 5-substituted 4'-thiopyrimidine nucleosides against orthopoxvirus infections.Development of drugs for Epstein-Barr virus using high-throughput in silico virtual screeningSuppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenineHistorical perspectives in the development of antiviral agents against poxvirusesAntiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonatesEffect of 5-iodo-2'-deoxyuridine on vaccinia virus (orthopoxvirus) infections in mice.Antivaccinia activities of acyclic nucleoside phosphonate derivatives in epithelial cells and organotypic cultures.Transport of 9-(2-phosphonomethoxyethyl)adenine across plasma membrane of HeLa S3 cells is protein mediatedEffective chemotherapy of equine herpesvirus 1 by phosphonylmethoxyalkyl derivatives of adenine demonstrated in a novel murine model for the disease.Acyclic nucleosides as antiviral compounds.Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus.Synthesis and antiviral evaluation of novel 2',2'-difluoro 5'-norcarbocyclic phosphonic acid nucleosides as antiviral agents.Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro.Diethyl (6-amino-9H-purin-9-yl) methylphosphonate induces apoptosis and cell cycle arrest in hepatocellular carcinoma BEL-7402 cells: Role of reactive oxygen species.Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir.Explicit solvent molecular dynamics simulation of duplex formed by the modified oligonucleotide with alternating phosphate/phosphonate internucleoside linkages and its natural counterpart.Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in mice.Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice.Inhibitory effects of 9-(2-phosphonylmethoxyethyl)adenine and 3'-azido-2',3'-dideoxythymidine on tumor development in mice inoculated intracerebrally with Moloney murine sarcoma virus.Efficacy of 9-(2-phosphonylmethoxyethyl)adenine in the therapy of TK+ and TK- herpes simplex virus experimental keratitis.Comparative activity of various compounds against clinical strains of herpes simplex virus.
P2860
Q28323687-4D7E16C5-EA19-4351-B821-43CB3FB5CD3AQ28328542-D98B580B-A9E2-4AAC-9FB5-86315116326CQ28340432-1A9BBA56-71C5-4B41-A727-3D61D66B5138Q28345238-45E23D2B-0217-4A57-BCD2-C0E11C0CA934Q28362129-2C8567A0-CF86-47A3-AC49-A703BBAC4C4CQ28369111-BDB58603-B693-4CDA-A531-BBFE35D896CEQ28378681-67504753-3D9D-4974-A2E6-E1D9A9C89DF1Q28396760-A86B209D-5858-47DD-9930-9383681D9C95Q34107597-B0ADCD55-9D29-4B82-995A-CC96E25E5A88Q34429807-80B8448A-E9AA-45C2-B650-03ED3F1BC2BAQ34464655-3F179363-BEC4-4862-9EE6-FC58A2689D35Q35119748-704B383F-3693-4804-B123-A78555C6DCB5Q35375912-1D0C11D3-5BA3-418B-A352-B1BEFD2D8A37Q35900309-FF1A2355-ADF9-4746-A7E2-3BFE3D35FBE0Q36074391-59D6CB1D-E1A5-4DC3-8844-E52FBC4A6AD2Q36295406-9A91FE14-8D13-47D5-99DE-AB22CBAA24FDQ37072113-4AE66D34-D038-4F4C-A894-C502DA79B0CCQ37278489-E09E74FC-A4F5-4769-B348-A3274DA1F3F9Q37740890-25FBCDD2-B3FD-481E-83FA-89E76A6727E3Q38617932-97173B69-F13C-42DF-AA75-864AEE3EC1AFQ39652313-A753EDF2-66B4-40A4-8473-7413E87FCF82Q39652802-C8586D23-6734-426E-A707-1A8E5EF25FB3Q39657990-42122AC8-21DF-4F8B-BC06-BE9289DFC63FQ39778904-EB575C8F-A026-4FD0-8200-5A69449F0A33Q39815807-3DFD300A-9F27-4113-8E0E-B417A655FFE4Q41058515-221ABC15-48B5-4A77-B0E6-C258F17318A5Q41655592-07B45EC8-6A18-4FFE-99D6-5521E7BF1AEDQ42234101-2EBEF28F-67A2-427F-AA0D-72FE592C3E14Q42814993-7C95BAFF-2190-4D85-B57E-A68FB9AA80E6Q43042768-1FB4517F-1C0D-48F2-908D-2C754C3A1C99Q43661749-44D86FC6-D25B-4D3A-BE1C-4CD3595F3EEEQ43939678-47F88573-6D5E-4B1B-B4F2-7AB418A71CCAQ45437157-1767AD9C-EBFA-4117-8168-F97C5FDE9AC8Q45777188-E3DB8F9C-E19F-4C2B-BBDF-14D496A399BCQ45849481-D1C0D818-4A1F-40CF-A952-B2B6AA6A8162Q45863423-7A9AA8E7-342C-40EE-B5EB-C5276E5242B0Q45877282-ED761697-134E-456D-83DD-D42D3DF6B584
P2860
Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo
description
1989 nî lūn-bûn
@nan
1989 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Efficacy of phosphonylmethoxya ...... cinia virus infections in vivo
@ast
Efficacy of phosphonylmethoxya ...... cinia virus infections in vivo
@en
Efficacy of phosphonylmethoxya ...... cinia virus infections in vivo
@nl
type
label
Efficacy of phosphonylmethoxya ...... cinia virus infections in vivo
@ast
Efficacy of phosphonylmethoxya ...... cinia virus infections in vivo
@en
Efficacy of phosphonylmethoxya ...... cinia virus infections in vivo
@nl
prefLabel
Efficacy of phosphonylmethoxya ...... cinia virus infections in vivo
@ast
Efficacy of phosphonylmethoxya ...... cinia virus infections in vivo
@en
Efficacy of phosphonylmethoxya ...... cinia virus infections in vivo
@nl
P2860
P50
P356
P1476
Efficacy of phosphonylmethoxya ...... cinia virus infections in vivo
@en
P2093
E De Clercq
I Rosenberg
P2860
P304
P356
10.1128/AAC.33.2.185
P407
P577
1989-02-01T00:00:00Z